USSTOCK.TODAY
Market Closed
Log in Sign up

Immuron Limited ADR(IMRN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

IMRN
IMRN
Immuron Limited ADR
At close Nov 19 at 4:00 PM ET (Korea 11/20 06:00)
$0.85
-0.02 ▼ -1.89%
Nov 19 at 4:00 PM ET (Korea 11/20 06:00)
$0.85
+0.00 +0.00%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -0.34Insider Own ⓘ -Shs Outstand ⓘ 8.1MPerf Week ⓘ -6.31%
Market Cap ⓘ 0.01BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ 3.3MPerf Month ⓘ -12.37%
Enterprise Value ⓘ 0.00BPEG ⓘ -EPS next Q ⓘ 0Inst Own ⓘ 1.95%Short Float ⓘ 0.8%Perf Quarter ⓘ -24.11%
Income ⓘ -0.00BP/S ⓘ 1.31EPS this Y ⓘ 98.15%Inst Trans ⓘ 11.11%Short Ratio ⓘ 0.01Perf Half Y ⓘ -13.27%
Sales ⓘ 0.01BP/B ⓘ 0.89EPS next 5Y ⓘ -ROA ⓘ -31.68%Short Interest ⓘ 0.03MPerf YTD ⓘ 11.48%
Book/sh ⓘ 0.96P/C ⓘ 1.1EPS past 3/5Y ⓘ 9.11% 21.57%ROE ⓘ -38.31%52W High ⓘ -57.29% ($1.99)Perf Year ⓘ -44.44%
Cash/sh ⓘ 0.77P/FCF ⓘ -Sales past 3/5Y ⓘ 62.68% 116.97%ROIC ⓘ -32.25%52W Low ⓘ 25.65% ($0.68)Perf 3Y ⓘ -53.3%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 42.44%Gross Margin ⓘ 64.54%Volatility(W/M) ⓘ 9.45% 7.5%Perf 5Y ⓘ -75.29%
Dividend TTM ⓘ -EV/Sales ⓘ 0.12Sales Y/Y TTM ⓘ 10.41%Oper. Margin ⓘ -61.63%ATR (14) ⓘ 0.07Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 5.98EPS Q/Q ⓘ 48.4%Profit Margin ⓘ -47.78%RSI (14) ⓘ 37.93Recom ⓘ 2
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 7.26Sales Q/Q ⓘ 18.7%SMA20 ⓘ -4.36% ($0.89)Beta ⓘ 1.18Target Price ⓘ $2.65
Payout ⓘ -Debt/Eq ⓘ 0Earnings ⓘ 2026/8/27SMA50 ⓘ -17.71% ($1.03)Rel Volume ⓘ 0Prev Close ⓘ $0.87
Employees ⓘ -LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -5.41% -9.85%SMA200 ⓘ -15.83% ($1.01)Avg Volume(3M) ⓘ 2.03MPrice ⓘ $0.85
IPO ⓘ 2017/3/2Option/Short ⓘ No/YesTrades ⓘ 48Volume ⓘ 6,513Change ⓘ -1.89%
Company
IMRN IMRNImmuron Limited ADR | NASD | Biotechnology Deep dive

🦠 (Immuron) is a commercial- and clinical-stage biopharmaceutical micro-cap company headquartered in Melbourne, Australia. Its core product is Travelan®, an oral immunotherapy that prevents travelers' diarrhea, generating revenue through over-the-counter (OTC) and dietary-supplement channels in Australia and the United States, while the company simultaneously develops a clinical-stage antibody pipeline that includes IMM-529.

Quote

Over the past 1 year, on the lower side

57% below its 1-year high.

Now $0.85
52w low$0.6852w high$1.99
52W Range13%
Volume ⓘ 6,513

Traded less than usual. That is 0% of its average volume.

B
Overall · fairly good
We judged 5 of the 8 questions below. 2 rate excellent and 2 need caution.
No data for earnings, outlook, dividends, or not applicable.
Peer comparison Biotechnology

It ranks #521 of 598 in the industry

Based on market cap of $7M.

FAQ

FAQ

What kind of company is IMRN?

IMRN belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of IMRN?

The market cap of IMRN is approximately $7M, ranking 5,476 within its sector.

What is the 52-week high and low for IMRN?

IMRN has recorded a 52-week high of $1.99 and a low of $0.68.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels